Full Breakdown
Understanding Inherited Retinal Dystrophies and Refsum Disease: Prevalence and Awareness
9/11/2025, 12:08:49 PM
Prevalence of Inherited Retinal Dystrophies in Europe
A recent meta-analysis has revealed that inherited retinal dystrophies (IRDs) are more prevalent in Europe than previously estimated. It is now believed that approximately 1 in 2,300 individuals in Western countries are affected, translating to an estimated 150,000 to 307,000 patients across the European Union and the United Kingdom. This group of genetic disorders often leads to progressive vision loss, typically manifesting at a young age. The study utilized an AI-supported search algorithm to analyze data from 15 observational studies across countries including the United Kingdom, France, Spain, and Italy. The estimated prevalence was calculated at 0.428 per 1,000 individuals, with a noted underestimation of patient numbers by about 30% due to incomplete disease registration and coding limitations.
Refsum Disease: A Rare Metabolic Disorder
Refsum disease, a rare metabolic disorder, affects approximately 1 in a million people in the United Kingdom, though its prevalence in Australia remains undetermined. This condition is characterized by a range of symptoms, including retinitis pigmentosa (RP), which is a group of inherited eye disorders leading to various types of vision loss. RP affects about 1 in 4,000 people globally and is also a significant symptom of Refsum disease.
Sharon Burstin, who was diagnosed with Refsum disease after a lengthy 40-year journey, emphasizes the need for greater awareness among general practitioners (GPs) regarding the condition. Her experience highlights the challenges faced by patients, as a retrospective review of 23 individuals with Refsum disease indicated an average delay of 11 years between their initial presentation to eye care practitioners and receiving a definitive diagnosis.
The Importance of Awareness and Education
Burstin advocates for increased education about rare diseases like Refsum, noting that medical training often focuses on more common genetic disorders, leaving gaps in knowledge about less prevalent conditions. She has connected with a global community of Refsum patients and recently collaborated with the US-based DARE Foundation to host a webinar aimed at raising awareness.
Burstin asserts, “Awareness will raise the chance of diagnosis exponentially, and ensure people get the life they deserve.” This sentiment underscores the critical need for improved recognition of rare diseases among healthcare professionals to facilitate timely and accurate diagnoses.
Criticism of Current Medical Training
The lack of emphasis on rare diseases in medical education has been criticized by Burstin, who points out that many medical students are not taught about conditions like Refsum disease. This gap in training can lead to significant delays in diagnosis and treatment for patients suffering from these disorders.
Conclusion
The findings regarding the prevalence of inherited retinal dystrophies and the advocacy for Refsum disease awareness highlight the importance of understanding and recognizing rare genetic conditions. Enhanced education and awareness among healthcare providers can lead to better diagnostic practices and improved patient outcomes.
